Physician profile
Michael G Gonzalez
NPI 1740265982
$30,604.88
in general payments reported to CMS, 2019-2025
6 companies · $4,206 in 2025
The $4,206 reported for 2025 was more than what 98% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $5,148 · 2021: $6,528 · 2022: $2,305 · 2023: $7,009 · 2024: $5,409 · 2025: $4,206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Travel and Lodging: $1,891 · Food and Beverage: $97.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,636.00 |
| Travel and Lodging | $1,890.71 |
| Food and Beverage | $97.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vapotherm INC | $30,322.55 | 2020-2025 | Vapotherm |
| Stryker Corporation | $153.24 | 2022 | |
| Acist Medical Systems, INC. | $54.00 | 2021 | |
| Glaxosmithkline, LLC. | $37.02 | 2025 | Shingrix, Arexvy |
| Xeris Pharmaceuticals, INC. | $21.49 | 2023 | Gvoke Hypopen |
| Sanofi-Aventis U.S. LLC | $16.58 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.